Anwaar Saeed

Trials

Studies that name Anwaar Saeed as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:34 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06896188 · 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

  Anwaar Saeed · recruiting · Pancreatic Adenocarcinoma · principal investigator
• Ph1/Ph2
  NCT06811116 · Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

  National Cancer Institute (NCI) · recruiting · Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 · principal investigator
• Ph2/Ph3
  NCT06203600 · Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

  National Cancer Institute (NCI) · recruiting · Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma · principal investigator
• Ph1
  NCT05803382 · Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  National Cancer Institute (NCI) · recruiting · Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Neoplasm, Stage IV Colorectal Cancer AJCC v8 · principal investigator
• Ph2
  NCT05239182 · 9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma

  Anwaar Saeed · terminated · Pancreatic Adenocarcinoma · principal investigator
• Ph1/Ph2
  NCT04440735 · A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors

  Kahr Medical · active not recruiting · Advanced Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer · principal investigator
• Ph1/Ph2
  NCT03995017 · Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma

  University of Kansas Medical Center · unknown · Esophagus Cancer, Adenocarcinoma, Stomach Cancer, Adenocarcinoma · principal investigator
• Ph2
  NCT03831698 · Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)

  University of Kansas Medical Center · unknown · Colorectal Cancer, Lynch Syndrome · principal investigator
• Ph1/Ph2
  NCT03539822 · Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

  Anwaar Saeed · recruiting · Gastric Cancer, Esophageal Adenocarcinoma, Hepatocellular Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• NCI ETCTN Pittsburgh Cancer Consortium (PCC)
  UM1CA186690 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD, Farshid Dayyani, Liza Cosca Villaruz · fiscal years 2014 to 2026
  Named on NCT06811116, NCT05803382
• SWOG Network Group Operations Center of the NCTN
  U10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAWN HERSHMAN, PRIMO N. LARA · fiscal years 2014 to 2026
  Named on NCT06203600